-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q+06lNdHl5ma+xrEVWBK9ZbX29FcaL9zHworFUDmgHm0EaZkTuv8VrkTpp4Z4ntU tuXcPcbk4Sf0zKaRU6/fYA== 0001013594-09-001069.txt : 20090515 0001013594-09-001069.hdr.sgml : 20090515 20090515172300 ACCESSION NUMBER: 0001013594-09-001069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090513 FILED AS OF DATE: 20090515 DATE AS OF CHANGE: 20090515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DellaCamera Capital Management, LLC CENTRAL INDEX KEY: 0001391052 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 09834660 BUSINESS ADDRESS: STREET 1: 461 FIFTH AVENUE STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 808-3590 MAIL ADDRESS: STREET 1: 461 FIFTH AVENUE STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 oscientfm4-051509_ex.xml MAY 15, 2009 X0303 4 2009-05-13 1 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001391052 DellaCamera Capital Management, LLC 461 FIFTH AVENUE 10TH FLOOR NEW YORK NY 10017 0 0 1 0 Common Stock 2009-05-13 4 S 0 416391 0.2509 D 576392 D Common Stock 2009-05-13 4 S 0 108162 0.2304 D 468230 D Common Stock 2009-05-14 4 S 0 468230 0.2096 D 0 D 12.50% Convertible Guaranteed Senior Notes due 2011 1.10 2009-05-13 4 S 0 500000 20.00 A Common Stock 454545 4500291 D 12.50% Convertible Guaranteed Senior Notes due 2011 1.10 2009-05-14 4 S 0 500000 20.00 A Common Stock 454545 4000291 D 12.50% Convertible Guaranteed Senior Notes due 2011 1.10 2009-05-14 4 S 0 1000000 19.00 A Common Stock 909090 3000291 D Reflects the securities of the issuer owned directly by DellaCamera Capital Master Fund, Ltd. (the "Master Fund"). DellaCamera Capital Management, LLC ("DCM") acts as the investment manager of the Master Fund. DellaCamera Capital Fund, Ltd. (the "Offshore Fund") is the controlling shareholder of the Master Fund. Ralph DellaCamera, Jr., Andrew Kurtz and Vincent Spinnato are the controlling persons of DCM (collectively, Messrs. DellaCamera, Kurtz and Spinnato shall be referred to as the "Controlling Persons"). DCM, the Offshore Fund and each Controlling Person may each be deemed to indirectly beneficially own the securities reported herein held by the Master Fund. For purposes of this Form 4, DCM, the Offshore Fund and each Controlling Person each disclaims ownership of the securities reported herein owned by the Master Fund, except to the extent of their pecuniary interest therein. The initial conversion rate of the issuer's 12.50% Convertible Guaranteed Senior Notes due 2011 (the "Notes") is 909.0909 shares per $1,000 principal amount of Notes (equal to a conversion price of approximately $1.10 per share). The Notes are immediately convertible into shares of common stock. These Notes mature on January 15, 2011, unless earlier converted or repurchased. Vincent Spinnato, Managing Member 2009-05-15 EX-99 2 oscientex99-051509.txt JOINT FILER INFORMATION Joint Filer Information Title of Security: Common Stock and 12.50% Convertible Guaranteed Senior Notes due 2011 Issuer & Ticker Symbol: Oscient Pharmaceuticals Corporation (OSCI) Designated Filer: DellaCamera Capital Management, LLC Other Joint Filers: DellaCamera Capital Master Fund, Ltd. ("Master Fund"); DellaCamera Capital Fund, Ltd. (the "Offshore Fund"); Ralph DellaCamera, Jr.; Andrew Kurtz; and Vincent Spinnato Addresses: The address of each of Messrs. DellaCamera, Kurtz and Spinnato is 461 Fifth Avenue, 10th Floor, New York, New York 10017. The address of each of the Master Fund and Offshore Fund is is c/o Ogier Fiduciary Services (Cayman) Limited, Queensgate House, PO Box 1234, Grand Cayman KY1-1108, Cayman Islands Signatures: Dated: May 15, 2009 DELLACAMERA CAPITAL MASTER FUND, LTD. By: /s/ Andrew Kurtz ------------------------------ Andrew Kurtz, Director DELLACAMERA CAPITAL FUND, LTD. By: /s/ Andrew Kurtz ------------------------------ Andrew Kurtz, Director /s/ Ralph DellaCamera, Jr. ---------------------------------- Ralph DellaCamera, Jr. /s/ Andrew Kurtz ------------------------------ Andrew Kurtz /s/ Vincent Spinnato ------------------------------ Vincent Spinnato -----END PRIVACY-ENHANCED MESSAGE-----